Search research articles
Contact Us
Filters
Showing results (851-860 of 1,171) with videos related to
Page
of 118
Sort By:
DNA Repair
|
September 10, 2019
Functional profiling of nucleotide Excision repair in breast cancer
Anne S Rajkumar-Calkins, Raphael Szalat, Matija Dreze, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors
D J Marsh, Z Zheng, A Arnold, et al.
International Journal of Molecular Sciences
|
November 3, 2025
RETRACTED: Bartlett et al. Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models. <i>Int. J. Mol. Sci.</i> 2018, <i>19</i>, 2685
David E Bartlett, Richard B Miller, Scott Thiesfeldt, et al.
JCI Insight
|
July 14, 2026
A whole-blood cryopreservation method streamlines clinical sample collection for multimodal single-cell immune profiling in sepsis
Alyssa K DuBois, Pierre O Ankomah, Alexis C Campbell, et al.
Schizophrenia Research
|
February 23, 2019
Impact of "psychosis risk" identification: Examining predictors of how youth view themselves
Lawrence H Yang, Kristen A Woodberry, Bruce G Link, et al.
JNCI Cancer Spectrum
|
April 25, 2020
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients
Nicole G Chau, Clement Ma, Kristina Danga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors
Leena Gandhi, Rastislav Bahleda, Sara M Tolaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014
Wells A Messersmith, Geoffrey I Shapiro, James M Cleary, et al.
The Oncologist
|
March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
Anthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
ESMO Open
|
August 29, 2022
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
V Boni, B Pistilli, I Braña, et al.
Page
of 118
Search research articles
Search
Showing results (851-860 of 1,171) with videos related to
Sort By:
Page
of 118
DNA Repair
|
September 10, 2019
Functional profiling of nucleotide Excision repair in breast cancer
Anne S Rajkumar-Calkins, Raphael Szalat, Matija Dreze, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors
D J Marsh, Z Zheng, A Arnold, et al.
International Journal of Molecular Sciences
|
November 3, 2025
RETRACTED: Bartlett et al. Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models. <i>Int. J. Mol. Sci.</i> 2018, <i>19</i>, 2685
David E Bartlett, Richard B Miller, Scott Thiesfeldt, et al.
JCI Insight
|
July 14, 2026
A whole-blood cryopreservation method streamlines clinical sample collection for multimodal single-cell immune profiling in sepsis
Alyssa K DuBois, Pierre O Ankomah, Alexis C Campbell, et al.
Schizophrenia Research
|
February 23, 2019
Impact of "psychosis risk" identification: Examining predictors of how youth view themselves
Lawrence H Yang, Kristen A Woodberry, Bruce G Link, et al.
JNCI Cancer Spectrum
|
April 25, 2020
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients
Nicole G Chau, Clement Ma, Kristina Danga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors
Leena Gandhi, Rastislav Bahleda, Sara M Tolaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014
Wells A Messersmith, Geoffrey I Shapiro, James M Cleary, et al.
The Oncologist
|
March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
Anthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
ESMO Open
|
August 29, 2022
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
V Boni, B Pistilli, I Braña, et al.
Page
of 118